FDA inspects Hiland Dairy Foods Company LLC, Inc. facility in Memphis on April 16, 2024

James “Jim” Sigg FDA%27s Deputy Commissioner for Operations and Chief Operating Officer - Official Website
James “Jim” Sigg FDA%27s Deputy Commissioner for Operations and Chief Operating Officer - Official Website
0Comments

The Food and Drug Administration (FDA) conducted an inspection of Hiland Dairy Foods Company LLC, Inc. in Memphis on April 16, 2024, according to data posted on the FDA’s website.

The inspection covered the following areas:

  • Foodborne Biological Hazards
  • Technical Assistance: Food and Cosmetics

The FDA’s final report concluded that Hiland Dairy Foods Company LLC, Inc. was not required to take any corrective actions regarding the management of its operations.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.

Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA - Official Website

Sweetbio, Inc. in Memphis inspected by FDA on July 24, 2024

The FDA conducted an inspection at Sweetbio, Inc. in Memphis on July 24, 2024, focusing on device compliance and post-market assurance for devices.

Robert M. Califf, M.D. Commissioner of Food and Drugs - FDA - Official Website

FDA inspection conducted Dec. 18, 2024, at Memphis VA Medical Center IRB in Memphis

On December 18, 2024, the FDA conducted a bioresearch monitoring inspection at the Memphis VA Medical Center IRB in Memphis, as reported on the FDA’s website.

Mark Raza Principal Deputy Chief Counsel - FDA - Official Website

FDA conducts inspection of Mark S. LeDoux, M.D. in Memphis on Sept. 30, 2024

According to FDA data, an inspection focused on bioresearch monitoring was conducted at Mark S. LeDoux, M.D. in Memphis on September 30, 2024.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Memphis Standard.